Quadrant Capital Group’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-420
| Closed | -$61.2K | – | 2764 |
|
|
2024
Q3 | $61.2K | Hold |
420
| – | – | ﹤0.01% | 1343 |
|
|
2024
Q2 | $57.7K | Hold |
420
| – | – | ﹤0.01% | 1332 |
|
|
2024
Q1 | $57.6K | Hold |
420
| – | – | ﹤0.01% | 1308 |
|
|
2023
Q4 | $57.1K | Hold |
420
| – | – | ﹤0.01% | 1320 |
|
|
2023
Q3 | $51.4K | Buy |
+420
| New | +$51.4K | 0.01% | 1249 |
|
|
2023
Q2 | – | Sell |
-164
| Closed | -$21.2K | – | 2726 |
|
|
2023
Q1 | $21.2K | Buy |
+164
| New | +$21.2K | ﹤0.01% | 1674 |
|
|
2022
Q4 | – | Sell |
-40
| Closed | -$5K | – | 2784 |
|
|
2022
Q3 | $5K | Sell |
40
-45
| -53% | -$5.63K | ﹤0.01% | 2134 |
|
|
2022
Q2 | $10K | Hold |
85
| – | – | ﹤0.01% | 1654 |
|
|
2022
Q1 | $11K | Sell |
85
-100
| -54% | -$12.9K | ﹤0.01% | 1600 |
|
|
2021
Q4 | $28K | Hold |
185
| – | – | ﹤0.01% | 1141 |
|
|
2021
Q3 | $30K | Hold |
185
| – | – | ﹤0.01% | 1067 |
|
|
2021
Q2 | $30K | Hold |
185
| – | – | ﹤0.01% | 1037 |
|
|
2021
Q1 | $28K | Hold |
185
| – | – | ﹤0.01% | 1032 |
|
|
2020
Q4 | $28K | Hold |
185
| – | – | 0.01% | 960 |
|
|
2020
Q3 | $25K | Sell |
185
-840
| -82% | -$114K | 0.01% | 874 |
|
|
2020
Q2 | $140K | Buy |
1,025
+690
| +206% | +$94.2K | 0.03% | 355 |
|
|
2020
Q1 | $36K | Hold |
335
| – | – | 0.01% | 1024 |
|
|
2019
Q4 | $39K | Buy |
+335
| New | +$39K | ﹤0.01% | 1457 |
|
|
2018
Q4 | – | Sell |
-1,050
| Closed | -$128K | – | 2237 |
|
|
2018
Q3 | $128K | Hold |
1,050
| – | – | 0.04% | 338 |
|
|
2018
Q2 | $115K | Hold |
1,050
| – | – | 0.04% | 360 |
|
|
2018
Q1 | $111K | Buy |
+1,050
| New | +$111K | 0.04% | 377 |
|